James Hippel
2022
In 2022, James Hippel earned a total compensation of $4.4M as Executive Vice President and CFO at Bio-Techne, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,289,740 |
|---|---|
| Option Awards | $1,874,812 |
| Salary | $636,600 |
| Stock Awards | $624,760 |
| Other | $10,117 |
| Total | $4,436,029 |
Hippel received $1.9M in option awards, accounting for 42% of the total pay in 2022.
Hippel also received $1.3M in non-equity incentive plan, $636.6K in salary, $624.8K in stock awards and $10.1K in other compensation.
Rankings
In 2022, James Hippel's compensation ranked 748th out of 5,756 executives tracked by ExecPay. In other words, Hippel earned more than 87.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 748 out of 5,756 | 87th |
Division Manufacturing | 333 out of 3,133 | 89th |
Major group Chemicals And Allied Products | 106 out of 1,419 | 93rd |
Industry group Drugs | 93 out of 1,320 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 20 out of 291 | 93rd |
Source: SEC filing on September 14, 2022.
Hippel's colleagues
We found five more compensation records of executives who worked with James Hippel at Bio-Techne in 2022.